New and emerging strategies for reducing cardiometabolic risk factors.

about

Metabolic syndrome in Thai schizophrenic patients: a naturalistic one-year follow-up study Effect of high-dose alpha-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease.

P2860

Q35793800-A473DBD2-37B6-41ED-B9DD-768BD8AB0591 Q37218342-D7791F47-5826-4D61-850B-C53367FC17B7

P2860

New and emerging strategies for reducing cardiometabolic risk factors.

Item

http://www.wikidata.org/entity/Q36459419

description

2006 nî lūn-bûn

@nan

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

2006年學術文章

@zh

2006年學術文章

@zh-hant

name

New and emerging strategies for reducing cardiometabolic risk factors.

@ast

New and emerging strategies for reducing cardiometabolic risk factors.

@en

type

Item

label

New and emerging strategies for reducing cardiometabolic risk factors.

@ast

New and emerging strategies for reducing cardiometabolic risk factors.

@en

prefLabel

New and emerging strategies for reducing cardiometabolic risk factors.

@ast

New and emerging strategies for reducing cardiometabolic risk factors.

@en

P1476

New and emerging strategies for reducing cardiometabolic risk factors.

@en

P2093

Dawn C Fuke

http://www.w3.org/2001/XMLSchema#string

Philip T Rodgers

http://www.w3.org/2001/XMLSchema#string

P2860

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

Efficacy and safety of a novel cholesteryl ester transfer protein inhibitor, JTT-705, in humans: a randomized phase II dose-response study

Raising high-density lipoprotein in humans through inhibition of cholesteryl ester transfer protein: an initial multidose study of torcetrapib

Pharmacologic and surgical management of obesity in primary care: a clinical practice guideline from the American College of Physicians

P304

13S-31S; quiz 43S-45S

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1592/PHCO.26.5PART2.13S

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

5 Pt 2

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2006-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16637783

http://www.w3.org/2001/XMLSchema#string

New and emerging strategies for reducing cardiometabolic risk factors.

about

P2860

P2860

New and emerging strategies for reducing cardiometabolic risk factors.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698